8 research outputs found

    Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy

    Get PDF
    IMPORTANCE Delays in screening programs and the reluctance of patients to seek medical attention because of the outbreak of SARS-CoV-2 could be associated with the risk of more advanced colorectal cancers at diagnosis. OBJECTIVE To evaluate whether the SARS-CoV-2 pandemic was associated with more advanced oncologic stage and change in clinical presentation for patients with colorectal cancer. DESIGN, SETTING, AND PARTICIPANTS This retrospective, multicenter cohort study included all 17 938 adult patients who underwent surgery for colorectal cancer from March 1, 2020, to December 31, 2021 (pandemic period), and from January 1, 2018, to February 29, 2020 (prepandemic period), in 81 participating centers in Italy, including tertiary centers and community hospitals. Follow-up was 30 days from surgery. EXPOSURES Any type of surgical procedure for colorectal cancer, including explorative surgery, palliative procedures, and atypical or segmental resections. MAIN OUTCOMES AND MEASURES The primary outcome was advanced stage of colorectal cancer at diagnosis. Secondary outcomes were distant metastasis, T4 stage, aggressive biology (defined as cancer with at least 1 of the following characteristics: signet ring cells, mucinous tumor, budding, lymphovascular invasion, perineural invasion, and lymphangitis), stenotic lesion, emergency surgery, and palliative surgery. The independent association between the pandemic period and the outcomes was assessed using multivariate random-effects logistic regression, with hospital as the cluster variable. RESULTS A total of 17 938 patients (10 007 men [55.8%]; mean [SD] age, 70.6 [12.2] years) underwent surgery for colorectal cancer: 7796 (43.5%) during the pandemic period and 10 142 (56.5%) during the prepandemic period. Logistic regression indicated that the pandemic period was significantly associated with an increased rate of advanced-stage colorectal cancer (odds ratio [OR], 1.07; 95%CI, 1.01-1.13; P = .03), aggressive biology (OR, 1.32; 95%CI, 1.15-1.53; P < .001), and stenotic lesions (OR, 1.15; 95%CI, 1.01-1.31; P = .03). CONCLUSIONS AND RELEVANCE This cohort study suggests a significant association between the SARS-CoV-2 pandemic and the risk of a more advanced oncologic stage at diagnosis among patients undergoing surgery for colorectal cancer and might indicate a potential reduction of survival for these patients

    In vitro evidence for a new therapeutic approach in renal cell carcinoma

    No full text
    PURPOSE: Renal cell carcinoma (RCC) is the most lethal among the common urologic malignancies, comprising 3% of all human neoplasias; approximately 40% of patients eventually die of cancer progression. One third of patients who present with metastatic disease and up to 40% treated for localized disease generally experience recurrence. RCCs are characterized by high resistance to chemo-, radio- and immunotherapy. We recently discovered an endogenous enzymatic activity, which is particularly expressed in tumorigenic cell, endogenous non-telomerase reverse transcriptase (RT) of retrotrasposon / retroviral origin, as a specific target to induce proliferation arrest in a number of human carcinogenesis in vitro culture cell lines. METHODS: To address this possibility, we have employed RCC primary cell culture testing pharmacological inhibition, in vitro, by two characterized non nucleosidic RT inhibitors, nevirapine and efavirenz; next, we assessed morphological effects and analyzed putative modulation on gene expression profile. RESULTS: Both treatments reduced cell proliferation rate and induced morphological differentiation and gene expression reprogramming in different RCC analyzed tumor biomarkers. CONCLUSION: In this study we describe a new potential therapeutic approach to obtain considerable future benefits in renal carcinoma cure and attempt to establish a new possible pharmacological therapy based on oral drugs administration in renal RCC treatment

    The Fluid Joint: The Soft Spot of Micro- and Nanosystems

    No full text
    Fluid bridges are ubiquitous soft structures of finite size that conform to and link the surfaces of neighboring objects. Fluid joints, the specific type of fluid bridge with at least one extremity constrained laterally, display even more pronounced reactivity and self-restoration, which make them remarkably suited for assembly, actuation, and manipulation purposes. Their peculiar surface and bulk properties place fluid joints at the rich intersection of diverse scientific interests, and foster their widespread use throughout micro- and nanotechnology. A critical survey of the mechanics and of the manifold applications of fluid bridges and joints in micro- and nanosystems is presented here, along with current challenges and multidisciplinary perspectives.SCOPUS: re.jFLWINinfo:eu-repo/semantics/publishe

    The Fluid Joint: The Soft Spot of Micro- and Nanosystems

    No full text

    Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study

    No full text
    Background: The association between volume, complications and pathological outcomes is still under debate regarding colorectal cancer surgery. The aim of the study was to assess the association between centre volume and severe complications, mortality, less-than-radical oncologic surgery, and indications for neoadjuvant therapy.Methods: Retrospective analysis of 16,883 colorectal cancer cases from 80 centres (2018-2021). Outcomes: 30-day mortality; Clavien-Dindo grade >2 complications; removal of >= 12 lymph nodes; non-radical resection; neoadjuvant therapy. Quartiles of hospital volumes were classified as LOW, MEDIUM, HIGH, and VERY HIGH. Independent predictors, both overall and for rectal cancer, were evaluated using logistic regression including age, gender, AJCC stage and cancer site.Results: LOW-volume centres reported a higher rate of severe postoperative complications (OR 1.50, 95% c.i. 1.15-1.096, P = 0.003). The rate of >= 12 lymph nodes removed in LOW-volume (OR 0.68, 95% c.i. 0.56-0.85, P = 12 lymph nodes removed was lower in LOW-volume than in VERY HIGH-volume centres (OR 0.57, 95% c.i. 0.41-0.80, P = 0.001). A lower rate of neoadjuvant chemoradiation was associated with HIGH (OR 0.66, 95% c.i. 0.56-0.77, P < 0.001), MEDIUM (OR 0.75, 95% c.i. 0.60-0.92, P = 0.006), and LOW (OR 0.70, 95% c.i. 0.52-0.94, P = 0.019) volume centres (vs. VERY HIGH).Conclusion: Colorectal cancer surgery in low-volume centres is at higher risk of suboptimal management, poor postoperative outcomes, and less-than-adequate oncologic resections. Centralisation of rectal cancer cases should be taken into consideration to optimise the outcomes

    Self‐Assembled Photonic Structures

    No full text
    Photonic crystals have proven their potential and are nowadays a familiar concept. They have been approached from many scientific and technological flanks. Among the many techniques devised to implement this technology self-assembly has always been one of great popularity surely due to its ease of access and the richness of results offered. Self-assembly is also probably the approach entailing more materials aspects owing to the fact that they lend themselves to be fabricated by a great many, very different methods on a vast variety of materials and to multiple purposes. To these well-known material systems a new sibling has been born (photonic glass) expanding the paradigm of optical materials inspired by solid state physics crystal concept. It is expected that they may become an important player in the near future not only because they complement the properties of photonic crystals but because they entice the researchers' curiosity. In this review a panorama is presented of the state of the art in this field with the view to serve a broad community concerned with materials aspects of photonic structures and more so those interested in self-assembly.This work as supported by MICINN project MAT2009-07841, Consolider CSD2007-0046 and CSIC PIF08-016; M.I. and R.S. acknowledge the MICINN Ramon y Cajal programme, J.F.G. acknowledges the CSIC JAE programme, L.S.F. acknowledges the MICINN Juan de la Cierva programme.This work as supported by MICINN project MAT2009-07841, Consolider CSD2007-0046 and CSIC PIF08-016; M.I. and R.S. acknowledge the MICINN Ramon y Cajal programme, J.F.G. acknowledges the CSIC JAE programme, L.S.F. acknowledges the MICINN Juan de la Cierva programme.Peer reviewe

    Self-Assembled Photonic Structures

    No full text
    corecore